baber/WOPTO huggingface dataset:
Patent AU-2018253564-A1 (AU)
Title: Fixation device for securing a linear element to a workpiece
Inventor: EAVES FELMONT F
IPC: A61B17/04
Filed: 2018-10-25
Abstract: FIXATION DEVICE FOR SECURING A LINEAR ELEMENT TO A WORKPIECE Abstract A fixation device (100) for securing a linear element (40) to a workpiece (70) includes a contact component (101) and a fixation component (104). The contact component (101) typically includes (i) a first contact surface (102) for application to a workpiece and (ii) a first opening for receiving a linear element (40). The fixation component (104) typically secures a portion of the linear element (40) on a side of the first contact component (101) opposite the first, contact surface (102). The fixation component (104) engages the contact component (101) to prevent passage of the linear element's secured portion through the workpiece when a tension is applied to the linear element in a direction opposite the contact surface (102).
Patent AU-2018256060-A1 (AU)
Title: Anti-inflammatory agent
Inventor: NII TAKUYA
IPC: A61P43/00
Filed: 2018-04-10
Abstract: The present invention addresses the problem of providing a composition which is usable as a novel anti-inflammatory agent. Inflammation such as stomatitis, oral mucositis, gingivitis and pneumonia can be ameliorated and/or prevented by using a composition which comprises olanexidine or a pharmacologically acceptable salt thereof. Preferably, the composition according to the present invention further comprises a poloxamer which is a block copolymer comprising a polyoxypropylene (POP) chain sandwiched between two polyoxyethylene (POE) chains.
Patent AU-2018277228-A1 (AU)
Title: Tube element
Inventor: GERIG THOMAS
IPC: A61M25/06
Filed: 2018-06-01
Abstract: The invention relates to a tube element (1) for a device for introduction into a body passage, which tube element has a first tube element end and a second tube element end, a longitudinal dimension being formed between the first and second tube element end. The tube element (1) has a sheath (2) comprising an outer wall (3) and an inner wall (4). The sheath (2) has an external diameter (6), the longitudinal dimension being at least ten times the external diameter (6). A cross-sectional element (5) is arranged between the first and second tube element ends. The cross-sectional element (5) contains a plurality of opening arrangements (8, 9, 10), and the opening arrangements (8, 9, 10) can extend along the longitudinal dimension from the first tube element end to the second tube element end. Each opening arrangement (8, 9, 10) comprises a first opening (18, 19, 20) containing an insert element (38, 39, 40) and a second opening (28, 29, 30), the internal pressure of which can be changed by a pressure changing means.
Patent AU-2018285412-A1 (AU)
Title: Cyclic peptides for protection against respiratory syncytial virus
Inventor: GHASPARIAN ARIN
IPC: A61K38/16
Filed: 2018-06-13
Abstract: The present invention relates to a cyclic peptide, a conjugate comprising said cyclic peptide and a lipopeptide building block, a bundle of said conjugates, a synthetic virus-like particle comprising at least one bundle of conjugates and pharmaceutical compositions comprising the same. The present invention further relates to said cyclic peptide, said conjugate said bundle of conjugates, said synthetic virus-like particle and said pharmaceutical compositions for use as a medicament, preferably for use in a method for preventing of an infectious disease or reducing the risk of an infectious disease, more preferably for use in a method for preventing or reducing the risk of an infectious disease associated with or caused by a respiratory syncytial virus. In particular, the present invention relates to a cyclic peptide, wherein said cyclic peptide comprises an amino acid sequence (I), wherein said amino acid sequence (I) comprises the following amino acid sequence: X1-X2-X3-C4-X5-X6-X7-C8-X9-X10-X11-P12-I13-T14-N15-D16-Q17-K18-K19-L20-C21- X22-X23-X24-C25-X26-X27-X28-X29-X30 (SEQ ID NO: 1), wherein X1, X2, X3, X5, X6, X7, X9, X10, X11, X22, X23, X24, X26, X27, X28 and X29 are independently of each other an amino acid; C4, C8, C21 and C25 are independently of each other cysteine; P12 is proline; I13 is isoleucine; T14 is threonine; N15 is asparagine; D16 is aspartic acid; Q17 is glutamine; K18 and K19 are independently of each other lysine; L20 is leucine; and X30 is an amino acid or a deletion, wherein said cysteines C4 and C25 form a first disulfide bond and said cysteines C8 and C21 form a second disulfide bond.
Patent AU-2018288789-A1 (AU)
Title: Systems and techniques for launching a payload
Inventor: RUSSELL MARK C
IPC: F41A1/04
Filed: 2018-06-19
Abstract: This disclosure describes various techniques and systems for rapid low-cost access to suborbital and orbital space and accommodation of acceleration of sensitive payloads to space. For example, a distributed gas injection system may be used in a ram accelerator to launch multiple payloads through the atmosphere. Additionally or alternatively, multiple projectiles may assemble during flight through the atmosphere to transfer and/or resources to another projectile.
Patent AU-2018347532-A1 (AU)
Title: Encapsulated fragrance in compressed tablet
Inventor: FARMER RACHEL ANN
IPC: B01D53/28
Filed: 2018-10-12
Abstract: A tablet having a deliquescent desiccant and a fragrance encapsulated on or within a binding agent. The tablet is in a pressed form. A method of making a tablet involves providing a deliquescent desiccant, encapsulating a fragrance by spray drying the fragrance on a carbohydrate, combining the deliquescent desiccant and the carbohydrate encapsulated fragrance, and pressing the combination into the tablet.
Patent AU-2018351893-A1 (AU)
Title: Lidocaine N-oxide for use in the prophylaxis of sudden cardiac death
Inventor: PATTERSON LAURENCE HYLTON
IPC: A61K31/167
Filed: 2018-10-18
Abstract: A pharmaceutical composition comprising lidocaine N-oxide (LNO), or a pharmaceutically acceptable salt thereof, for use in a method of treatment, said method being a prophylactic treatment to prevent, or decrease the likelihood of, sudden cardiac death associated with ventricular fibrillation (VF) in a subject, whereby the composition is provided to the subject's bloodstream via the oral mucous membrane or via pulmonary absorption in the lungs or by IV administration.
Patent AU-2018358912-A1 (AU)
Title: Control boxes principally for use with equipment of swimming pools and spas
Inventor: UY DINDO
IPC: A61H33/00
Filed: 2018-10-25
Abstract: Control boxes (10) with segregated low- and high-voltage components are described. Service technicians (or others) requiring access to one set of components may do so without necessarily accessing the other set. Dual user interfaces may be utilized, further, with one interface being present at the control box and the other being remote therefrom.
Patent AU-2018408015-A1 (AU)
Title: Method and device for transmitting uplink control information
Inventor: LIN YANAN
IPC: H04W72/04
Filed: 2018-02-11
Abstract: Disclosed is a method for transmitting uplink control information. The method comprises: a terminal device determining an uplink control channel resource set according to a first number of bits, wherein the first number of bits is determined according to high-level parameters; the terminal device receiving configuration information, wherein the configuration information indicates one uplink control channel resource in the uplink control channel resource set; the terminal device determining, according to a channel format corresponding to the uplink control channel resource, first uplink control information to be transmitted, wherein the number of bits occupied by the first uplink control information is less than or equal to the first number of bits; and the terminal device using the channel format to transmit the first uplink control information in the one uplink control channel resource. Therefore, a terminal device determines, based on a channel format corresponding to an uplink control channel resource, uplink control information to be transmitted, so that the number of bits of actually transmitted uplink control information is less than or equal to the number of bits, determined according to high-level parameters, of uplink control information, thereby improving the transmission efficiency of uplink control information.
Patent AU-2018410946-A1 (AU)
Title: Waterproof wiring terminal and household appliance
Inventor: SHANG BIN
IPC: H01R24/00
Filed: 2018-12-29
Abstract: A waterproof wiring terminal and a household appliance, which relate to the technical field of waterproof household appliances. The waterproof wiring terminal (1) comprises a male connector (3) and a female connector (4). A male connector body (5) penetrates an insulation sleeve (6) and is fixedly connected to the insulation sleeve (6), and a water wiping pad (10) is installed inside of a female connector body (9); when the male connector (3) is inserted into the female connector (4), the male connector body (5) and the insulation sleeve (6) successively enter the water wiping pad (10), and the water wiping pad (10) produces a squeezing force on the male connector body (5) to stop water on the male connector body (5) outside of the water wiping pad (10), the water then flowing outside of the insulation sleeve (6), which prevents the water from becoming conducted by an electrical current. Since the waterproof wiring terminal (1) employs the insulation sleeve (6) that is sleeved outside of the male connector body (5) and the water wiping pad (10) that is installed inside of the female connector body (9), water on the male connector body (5) may be squeezed outside of the insulation sleeve (6), preventing the water from entering the female connector body (9) and causing the risk of electrical leakage. The waterproof connection terminal is convenient, practical, and safe to use.
Patent WO-2019218022-A1 (WO)
Title: Streptococcal toxic shock syndrome
Inventor: GOOD MICHAEL
IPC: A61K39/40
Filed: 2019-05-16
Abstract: Provided herein are methods of immunizing against, treating or preventing streptococcal toxic shock syndrome in a subject, by administration of a group A streptococcus M protein, inclusive of fragments, variants or derivatives thereof, or an antibody that binds, or is raised against the M protein and optionally a group A streptococcus superantigen protein, inclusive of fragments, variants or derivatives thereof, or an antibody or antibody fragment that binds, or is raised against, the superantigen protein.
Patent AU-2019201848-A1 (AU)
Title: Railcar adapter for connecting a railcar body to a bearing
Inventor: FENAYON LUDOVIC
IPC: B61F5/14
Filed: 2019-03-18
Abstract: RAILCAR ADAPTER FOR CONNECTING A RAILCAR BODY TO The invention relates to a railcar adapter (14) for radially connecting a railcar body to a bearing (16). The railcar adapter (14) comprises two lateral channels (42) each delimited by a pair of opposed lugs (42b, 42c) and a lateral guiding surface (42a) perpendicular to said opposed lugs (42b, 42c), lateral channels (42) being adapted to cooperate with the railcar body. The said lateral guiding surfaces (42a) of lateral channels (42), in cross-section through a plane perpendicular to the axis of rotation of bearing, are curved. Reference: Figure 1. 'It
Patent AU-2019203172-A1 (AU)
Title: Coupling for roller blind assembly
Inventor: BRICE MELVIN
IPC: E06B9/17
Filed: 2019-05-06
Abstract: Abstract A coupling arrangement (5) for use with a roller blind assembly is disclosed. In at least one embodiment, the coupling arrangement (5) comprise a first coupling portion (10) associated/associable with a portion of a supporting element (20) of the roller blind assembly, and a second coupling portion (15) associated/associable with a portion of an edge of a blind (25) of the roller blind assembly. The first (10) and second (20) coupling portions are configured for complementary engagement with each other such that winding of the blind about the supporting element provides, at least in part, a roll of the blind when wound being substantially uniform about the axis of the supporting element, or prevents, at least in part, the roll of the blind when wound being substantially non-uniform about a longitudinal axis of the supporting element. ww a I I
Patent AU-2019203638-A1 (AU)
Title: Azetidines as MEK inhibitors for the treatment of proliferative diseases
Inventor: KENNEDY ABIGAIL R
IPC: C07D409/12
Filed: 2019-05-24
Abstract: Abstract Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.
Patent AU-2019204019-A1 (AU)
Title: Blockchain asset issuing and redemption methods and apparatuses, and electronic device therefore
Inventor: HU DANQING
IPC: G06Q20/00
Filed: 2019-05-29
Abstract: Attorney Docket No. 44892-0313WO1/ PCT15826 One or more implementations of the present specification provide blockchain asset issuing and redemption methods and apparatuses, and an electronic device therefor. The method can include the following: determining, by a blockchain anchor, that an off-chain asset of a specified amount is in a frozen state indicating that the off-chain asset is isolated and protected from a plurality of factors. The blockchain anchor issues the blockchain asset on a blockchain, where an amount of the blockchain asset is not greater than the specified amount. The blockchain anchor publishes a transaction record of the blockchain asset in a blockchain ledger containing a freeze certificate for the off-chain asset. 61932263.docx
Patent AU-2019234828-A1 (AU)
Title: Beta glucan and CD40 agonist combination immunotherapy
Inventor: BOSE NANDITA
IPC: A61K39/00
Filed: 2019-03-13
Abstract: The present invention relates to the combination of β-glucan and a CD40 agonist for cancer immunotherapy. The combination therapy shows synergistic anti-tumor activity that is dependent on T cells. Surprisingly, the combination therapy is effective against poorly immunogenic tumors.
Patent AU-2019253803-A1 (AU)
Title: Device for mixing a bone cement with hollow space for monomer transfer
Inventor: VOGT SEBASTIAN
IPC: B01F33/40
Filed: 2019-10-22
Abstract: DEVICE FOR MIXING A BONE CEMENT WITH HOLLOW SPACE FOR MONOMER TRANSFER The invention relates to a device for the production of a bone cement dough from a monomer liquid (6) and a cement powder (5) comprising a cartridge (1) with an internal space; a cartridge head (2) with a dispensing opening; a conveying plunger (3) that is arranged in the internal space of the cartridge (1) and is supported in the internal space of the cartridge (1) such that it is pushable in the direction of the dispensing opening; a dispensing plunger (4) between the dispensing opening and the conveying plunger (3) that is supported in the internal space of the cartridge (1) such that it is pushable in the direction of the dispensing opening; a first hollow space, in which the cement powder (5) is arranged; a second hollow space (7) that is bordered by the dispensing plunger (4) and the conveying plunger (3); a fluid opening (8) that is arranged in the conveying plunger (3); a feedthrough (9) that connects the first hollow space and the second hollow space (7) to each other, and a closure means (10) that is arranged on a rear side of the dispensing plunger (4), whereby the closure means (10) projects away from the dispensing plunger (4) and is situated at a distance from the fluid opening (8), whereby the fluid opening (8) is closable with the closure means (10), and whereby the closure means (10) is appropriately mobile in the closed fluid opening (8, 108) such that the fluid opening (8) stays closed, while the conveying plunger (3) is pushable further in the direction of the dispensing plunger (4). The invention also relates to a method for production of a bone cement dough using a device of this type. (Figure 1) 44 -- 1 -- 42 -- 24 -~20 Figure 1
Patent AU-2019266171-A1 (AU)
Title: Pharmaceutical composition for controlled release of treprostinil
Inventor: KAN PEI
IPC: A61K31/573
Filed: 2019-05-06
Abstract: Provided herein are pharmaceutical compositions containing (a) at least one liposome includes at least one vesicle-forming phospholipid; and (b) treprostinil encapsulated within the liposome. The ratio of treprostinil to phospholipid is equal to or higher than 0.035 and provides a controlled release of treprostinil. Also provided is the use of the pharmaceutical compositions to treat respiratory diseases.
Patent AU-2019266400-A1 (AU)
Title: Low noise broadband amplifier with resistive matching
Inventor: TERRY ANDREW
IPC: H03F3/68
Filed: 2019-05-02
Abstract: Various circuitry may benefit from appropriate matching. For example, certain low noise broadband amplifiers may benefit from resistive matching.
Patent AU-2019301150-A1 (AU)
Title: Decentralized cybersecure privacy network for cloud communication and global e-commerce
Inventor: VERZUN LEVGEN
IPC: H04L12/701
Filed: 2019-07-10
Abstract: Software installed in the nodes in a communication network allows them to perform a ''name server'' function, which entails the management of a dynamic list of the client devices that are connected to the cloud, a ''task'' function, which entails the receipt and transmission of the packets, and an ''authority'' function, which entails the determination of the routes of the packets through the cloud. Each node is capable of performing only one function at a time. After completing a job, a node reverts to an undifferentiated, state awaiting its next performance request.
Patent AU-2019308266-A1 (AU)
Title: Methods for treatment of cancer using chikungunya-VSV chimeric virus
Inventor: VAN DEN POL ANTHONY N
IPC: A61K35/766
Filed: 2019-07-17
Abstract: Chimeric viruses having a vesicular stomatitis virus (VSV) background where the VSV G protein is supplemented or replaced with an alphavirus glycoprotein(s), or a functional fragment(s) thereof, are provided. A preferred alphavirus is Chikungunya virus. In particular embodiments, the glycoprotein(s) is or includes E3, E2, K6, and E1 proteins of an alphavirus, preferably Chikungunya virus. Methods of using the chimeric viruses for treatment of cancers, particularly brain cancers and metastasis thereof are also provided. In some embodiments, the chimeric viruses retain superior oncolytic activity to infect and destroy cancer cells selectively, such as glioblastoma and intracranial melanoma metastases. In some embodiments, the chimeric viruses have reduced toxicity to e.g., heathy cells relative to a control such as the parent VSV with the VSV G protein.
Patent AU-2019312672-A1 (AU)
Title: Apparatus and method for storing wave signals in a cavity
Inventor: DAMAGHI DANIEL
IPC: G02B5/09
Filed: 2019-08-01
Abstract: An apparatus comprising a cavity having interior surfaces or reflecting elements, one or more transmitters configured to receive an electrical signal, transform the electrical signal into an electromagnetic wave signal, and introduce the electromagnetic wave signal into an inside of the cavity, and one or more receivers configured to retrieve the electromagnetic wave signal, transform the electromagnetic wave signal to a corresponding electrical signal, and transmit the corresponding electrical signal to the outside of the cavity is disclosed. The electromagnetic wave signal is contained within the inside of the cavity until retrieved by undergoing a series of reflections or traversals between the interior surfaces of the cavity or the reflecting elements within the cavity. The apparatus may further comprise one or more regenerators configured to re-amplify, re-shape, and/or re-time the electromagnetic wave signal traveling within the inside of the cavity.
Patent AU-2019314882-A1 (AU)
Title: Fe-rich binder
Inventor: ARNOUT LUKAS
IPC: C04B28/04
Filed: 2019-07-31
Abstract: The invention relates to binders for mortar or concrete comprising a mixture consisting of: a) from 40 to 95 wt% of an Fe-comprising glass or Fe-comprising metallurgical slag, wherein the glass or slag comprises more than 30 wt% Fe, expressed as Fe203, b) from 1 to 40 wt% of a calcium comprising additive, wherein the additive comprises more than 30 wt% Ca, expressed as calcium oxide and c) from 0.5 to 20 wt% of an alkali, wherein the sum of the percentages of a) b) and c) in the mixture, calculated on a dry basis, is 100%.
Patent AU-2019325910-A1 (AU)
Title: Multi-view masters for graphical designs
Inventor: HSU VICTOR
IPC: G06F3/048
Filed: 2019-07-29
Abstract: A method for generating and using multi-view masters involves selecting a master in a design environment. A widget is added to the master. A first view is selected for the master. A first widget characterization of the widget is received. The first widget characterization is associated with the first view of the master. A second view of the master is selected. A second widget characterization of the widget is received. The second widget characterization is associated with the second view of the master. An instance of the master is placed in a containing context. A first instance view selection is received, the first instance view selecting the first view of the master for the first instance of the master. The first instance of the master is displayed within the containing context, the widget being displayed in accordance with the first widget characterization associated with the first view of the master.
Patent AU-2019340314-A1 (AU)
Title: Dynamic application migration between cloud providers
Inventor: HARI RAVI
IPC: G06F9/50
Filed: 2019-07-29
Abstract: A method that involves receiving budget information of a containerized application deployed with a set of containers to a first cloud provider service of a set of cloud provider services; receiving pricing information from each cloud provider service of the set of cloud provider services, wherein the set of cloud provider services includes the first cloud provider service and a second cloud provider service; receiving performance information of the containerized application from the first cloud provider service; generating an output vector from a machine learning model, wherein the machine learning model uses the pricing information and the performance information to generate the output vector; determining a first cloud provider service cost and a second cloud provider service cost based on the output vector and the pricing information; migrating the containerized application from the first cloud provider service to the second cloud provider service.
Patent AU-2019343906-A1 (AU)
Title: Corrosion-resistant coolant salt and method for making same
Inventor: KELLEHER BRIAN C
IPC: C09K5/12
Filed: 2019-09-16
Abstract: This document describes a method for reducing the corrosivity of certain magnesium salts. The salt product resulting from the method exhibits reduced corrosion of steels that come into contact with the salt relative to salt compositions that are not so treated. This makes such treated salts more efficient coolant salts as they will require less equipment replacement over time. The method uses magnesium metal to reduce unwanted impurities in the salts the reduced impurities are then removed as either gas or precipitate from the now purified salt. Without being bound to one particular theory, it is believed that the reduction of the level of impurities in the salt results in a salt with substantially reduced corrosiveness to steel.